Global Cold Agglutinin Disease Market Spotlight 2019: Key Pipeline Drugs, Clinical Trials, Probability of Success, Licensing, Acquisition Deals, and Epidemiology - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 5, 2019--
The “Market Spotlight: Cold Agglutinin Disease” report has been added to ResearchAndMarkets.com’s offering.
This Market Spotlight report covers the Cold Agglutinin Disease market, comprising disease background and treatment information, key pipeline drugs, clinical trials, probability of success, licensing and acquisition deals, and an epidemiology overview.
Key Topics Covered:
PROBABILITY OF SUCCESS
LICENSING AND ASSET ACQUISITION DEALS
CLINICAL TRIAL LANDSCAPE
Sponsors by status
Sponsors by phase
For more information about this report visit https://www.researchandmarkets.com/r/njlzqh
View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005510/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/05/2019 04:33 AM/DISC: 11/05/2019 04:33 AM